Taiho Oncology Announces Updated Efficacy and Safety Data fo

/PRNewswire/ -- Taiho Oncology, Inc. announced today updated results of the Phase 2 FOENIX-CCA2 trial of futibatinib, confirming results observed in an earlier...

Related Keywords

Oakville , Ontario , Canada , United States , New Jersey , Massachusetts , Boston , Switzerland , Chicago , Illinois , Canadian , American , Lipika Goyal , Judy Kay Moore , Volker Wacheck , Taiho Pharmaceutical Co Ltd , American Society Of Clinical Oncology , Hospital Cancer Center , Drug Administration , Taiho Oncology Inc , Cholangiocarcinoma Foundation , Prnewswire Taiho Oncology Inc , Otsuka Holdings Co Ltd , Clinical Development , American Cancer Society , New Drug Application , Clinical Oncology , Annual Meeting , Massachusetts General Hospital Cancer Center , Vice President , Taiho Oncology , Prescription Drug User Fee Act , Breakthrough Therapy Designation , Oncology Media Contact , Reviews Gastroenterology , Nc , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,